Skip to content

Evaluating Homoeopathy for Managing Global Developmental Delay in Children Alongside Standard Therapies

To assess the effectiveness of Individualized Homoeopathic Medicine using Complete Repertory with standard therapies in the management of global developmental delay in children : A Randomized Single-Blind Double-Arm Placebo-Controlled Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077817
Enrollment
70
Registered
2024-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F88- Other disorders of psychological development

Interventions

Intervention1: Homoeopathic Medicine: Oral route of administration Pill form 30 pill size Centesimal Scale Potency First dose after taking the case Subsequent doses after each follow up potency acco

Sponsors

Principal Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children under the age of 5 years of both sexes diagnosed with Global Developmental Delay (GDD), regardless of race, caste, religion, or socioeconomic status. Children who are currently receiving standard therapies, including: Occupational Therapy Language Therapy Speech Therapy Physiotherapy Children diagnosed with Global development delay along with other co-morbidities like: Autism Spectrum Disorder (ASD) Cerebral Palsy (CP) Attention-Deficit/Hyperactivity Disorder (ADHD) Down Syndrome Turner Syndrome Klinefelter Syndrome

Exclusion criteria

Exclusion criteria: Children with severe chronic physical disorders that might interfere with the assessment of GDD. Children who are severely ill and require hospitalization. Children with profound global developmental delay (SQ Below 20). Children with uncontrolled or unstable psychiatric conditions and severe neurodevelopmental disorders. Children with severe or profound sensory impairments (eg total blindness or deafness). Children who are currently involved in other clinical trials or interventions that might conflict with or bias the outcomes of this study. Children whose parents or guardians are unable to provide written informed consent or who do not comply with study requirements.

Design outcomes

Secondary

MeasureTime frame
NilTimepoint: Not Applicable

Primary

MeasureTime frame
At the end of this study, it is expected that Complete repertory will be of utility in selection of Homoeopathic similimum in the management of cases of GDD in children.Timepoint: 15 Months study 6 months Enrolment period 6 months Follow-up 3 months Report writing and Data Analysis

Countries

India

Contacts

Public ContactDr Aditi Goyal

Bakson Homoeopathic Medical College and Hospital

draditigoyal19@gmail.com9910797598

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026